Qube Research & Technologies LTD Forte Biosciences, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3 shares of FBRX stock, worth $21. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$21
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$25.5 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$23 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$21 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$14.3 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$12.9 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $143M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.